ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 11,086,909 | $10,087,979 | 15.03% |
Artal Group S.A. | 2,255,375 | $2,052 | 0.09% |
Redmile Group, LLC | 1,608,089 | $1,463,200 | 0.07% |
Forefront Analytics, LLC | 78,169 | $71,126 | 0.04% |
Baker Brothers Advisors | 2,557,149 | $2,326,750 | 0.01% |
Point72 Asset Management, L.P. | 1,413,809 | $1,286,425 | 0.00% |
XTX Topco Ltd | 21,084 | $19,184 | 0.00% |
Coppell Advisory Solutions LLC | 1,000 | $5,560 | 0.00% |
Renaissance Technologies | 437,528 | $398 | 0.00% |
JPMORGAN CHASE & CO | 989 | $900 | 0.00% |
ROYAL BANK OF CANADA | 35 | $0 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 13,105 | $11,924 | 0.00% |
BANK OF AMERICA CORP /DE/ | 73,242 | $66,577 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 21,590 | $19,644 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 16,278 | $14,811 | 0.00% |
MORGAN STANLEY | 50,020 | $45,513 | 0.00% |
Citadel Advisors | 57,626 | $52,434 | 0.00% |
Qube Research & Technologies Ltd | 73 | $66 | 0.00% |
External links
This page lists ACHILLES THERAPEUTICS PLC's shareholders in Q3 2023. To view ACHILLES THERAPEUTICS PLC's shareholder history, click here.